Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Evaluating the Effect of a Patient Decision Aid for Atrial Fibrillation Stroke Prevention Therapy.

Loewen PS, Bansback N, Hicklin J, Andrade JG, Kapanen AI, Kwan L, Lynd LD, McClean A, MacGillivray J, Salmasi S.

Ann Pharmacother. 2019 Feb 6:1060028019828420. doi: 10.1177/1060028019828420. [Epub ahead of print]

PMID:
30724102
2.

Communicating uncertainty in cancer prognosis: A review of web-based prognostic tools.

Harrison M, Han PKJ, Rabin B, Bell M, Kay H, Spooner L, Peacock S, Bansback N.

Patient Educ Couns. 2018 Dec 12. pii: S0738-3991(18)31017-6. doi: 10.1016/j.pec.2018.12.009. [Epub ahead of print] Review.

PMID:
30579771
3.

Early cost-effectiveness modeling for better decisions in public research investment of personalized medicine technologies.

Ling DI, Lynd LD, Harrison M, Anis AH, Bansback N.

J Comp Eff Res. 2019 Jan;8(1):7-19. doi: 10.2217/cer-2018-0033. Epub 2018 Dec 10.

PMID:
30525982
4.

Assessment of atrial fibrillation patients' education needs from patient and clinician perspectives: A qualitative descriptive study.

Salmasi S, Kwan L, MacGillivray J, Bansback N, De Vera MA, Barry AR, Harrison MJ, Andrade J, Lynd LD, Loewen P.

Thromb Res. 2019 Jan;173:109-116. doi: 10.1016/j.thromres.2018.11.015. Epub 2018 Nov 16.

PMID:
30502679
5.

Assessing an Interactive Online Tool to Support Parents' Genomic Testing Decisions.

Adam S, Birch PH, Coe RR, Bansback N, Jones AL, Connolly MB, Demos MK, Toyota EB, Farrer MJ, Friedman JM.

J Genet Couns. 2018 Jul 23. doi: 10.1007/s10897-018-0281-1. [Epub ahead of print]

PMID:
30033481
6.

The use of routinely collected patient-reported outcome measures in rheumatoid arthritis.

Hiligsmann M, Rademacher S, Kaal KJ, Bansback N, Harrison M.

Semin Arthritis Rheum. 2018 Dec;48(3):357-366. doi: 10.1016/j.semarthrit.2018.03.006. Epub 2018 Mar 15. Review.

PMID:
29709290
7.

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.

Bansback N, Guh D, Oviedo-Joekes E, Brissette S, Harrison S, Janmohamed A, Krausz M, MacDonald S, Marsh DC, Schechter MT, Anis AH.

Addiction. 2018 Jul;113(7):1264-1273. doi: 10.1111/add.14171. Epub 2018 Mar 28.

PMID:
29589873
8.

Testing and treatment for obstructive sleep apnea in Canada: funding models must change.

Pendharkar SR, Povitz M, Bansback N, George CFP, Morrison D, Ayas NT; Canadian Sleep and Circadian Network.

CMAJ. 2017 Dec 11;189(49):E1524-E1528. doi: 10.1503/cmaj.170393. No abstract available.

9.

Recognizing difficult trade-offs: values and treatment preferences for end-of-life care in a multi-site survey of adult patients in family practices.

Howard M, Bansback N, Tan A, Klein D, Bernard C, Barwich D, Dodek P, Nijjar A, Heyland DK.

BMC Med Inform Decis Mak. 2017 Dec 6;17(1):164. doi: 10.1186/s12911-017-0570-x.

10.

How Should Discrete Choice Experiments with Duration Choice Sets Be Presented for the Valuation of Health States?

Mulhern B, Norman R, Shah K, Bansback N, Longworth L, Viney R.

Med Decis Making. 2018 Apr;38(3):306-318. doi: 10.1177/0272989X17738754. Epub 2017 Oct 31.

PMID:
29084472
11.

Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates.

Harvard S, Guh D, Bansback N, Richette P, Saraux A, Fautrel B, Anis A.

Cost Eff Resour Alloc. 2017 Sep 7;15:20. doi: 10.1186/s12962-017-0081-8. eCollection 2017.

12.

Do Biologic Therapies for Rheumatoid Arthritis Offset Treatment-Related Resource Utilization and Cost? A Review of the Literature and an Instrumental Variable Analysis.

Bansback N, Fu E, Sun H, Guh D, Zhang W, Lacaille D, Milbers K, Anis AH.

Curr Rheumatol Rep. 2017 Sep;19(9):54. doi: 10.1007/s11926-017-0680-6. Review.

PMID:
28752490
13.

Testing the External Validity of a Discrete Choice Experiment Method: An Application to Latent Tuberculosis Infection Treatment.

Mohammadi T, Bansback N, Marra F, Khakban A, Campbell JR, FitzGerald JM, Lynd LD, Marra CA.

Value Health. 2017 Jul - Aug;20(7):969-975. doi: 10.1016/j.jval.2017.04.007. Epub 2017 May 19.

14.

Adherence to Antitumor Necrosis Factor Use Recommendations in Spondyloarthritis: Measurement and Effect in the DESIR Cohort.

Harvard S, Guh D, Bansback N, Richette P, Saraux A, Fautrel B, Anis AH.

J Rheumatol. 2017 Oct;44(10):1436-1444. doi: 10.3899/jrheum.161399. Epub 2017 Jul 1.

PMID:
28668809
15.

Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV.

Joyce VR, Sun H, Barnett PG, Bansback N, Griffin SC, Bayoumi AM, Anis AH, Sculpher M, Cameron W, Brown ST, Holodniy M, Owens DK.

MDM Policy Pract. 2017 Jul 3;2(2):2381468317716440. doi: 10.1177/2381468317716440. eCollection 2017 Jul-Dec.

16.

Decision aids for patients considering total joint replacement: a cost-effectiveness analysis alongside a randomised controlled trial.

Trenaman L, Stacey D, Bryan S, Taljaard M, Hawker G, Dervin G, Tugwell P, Bansback N.

Osteoarthritis Cartilage. 2017 Oct;25(10):1615-1622. doi: 10.1016/j.joca.2017.05.022. Epub 2017 Jun 15.

17.

Triple Therapy Versus Biologic Therapy for Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.

Bansback N, Phibbs CS, Sun H, O'Dell JR, Brophy M, Keystone EC, Leatherman S, Mikuls TR, Anis AH; CSP 551 RACAT Investigators.

Ann Intern Med. 2017 Jul 4;167(1):8-16. doi: 10.7326/M16-0713. Epub 2017 May 30.

PMID:
28554192
18.

Effects of a Web-Based Patient Decision Aid on Biologic and Small-Molecule Agents for Rheumatoid Arthritis: Results From a Proof-of-Concept Study.

Li LC, Shaw CD, Lacaille D, Yacyshyn E, Jones CA, Koehn C, Hoens AM, Geldman J, Sayre EC, Macdonald GG, Leese J, Bansback N.

Arthritis Care Res (Hoboken). 2018 Mar;70(3):343-352. doi: 10.1002/acr.23287. Epub 2018 Feb 6.

PMID:
28544648
19.
20.

OMERACT Quality-adjusted Life-years (QALY) Working Group: Do Current QALY Measures Capture What Matters to Patients?

Trenaman L, Boonen A, Guillemin F, Hiligsmann M, Hoens A, Marra C, Taylor W, Barton J, Tugwell P, Wells G, Bansback N.

J Rheumatol. 2017 Dec;44(12):1899-1903. doi: 10.3899/jrheum.161112. Epub 2017 Mar 15.

21.

A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the Elderly.

Osterhoff G, O'Hara NN, D'Cruz J, Sprague SA, Bansback N, Evaniew N, Slobogean GP.

Value Health. 2017 Mar;20(3):404-411. doi: 10.1016/j.jval.2016.10.017. Epub 2016 Dec 12.

22.

Health literacy and logical inconsistencies in valuations of hypothetical health states: results from the Canadian EQ-5D-5L valuation study.

Al Sayah F, Johnson JA, Ohinmaa A, Xie F, Bansback N; Canadian EQ-5D-5L Valuation Study Group.

Qual Life Res. 2017 Jun;26(6):1483-1492. doi: 10.1007/s11136-016-1495-z. Epub 2017 Jan 25.

PMID:
28124280
23.

Moving from outcomes to values to deliver high-quality health care-A new checklist for valuation studies.

Trenaman L, Bansback N.

J Clin Epidemiol. 2017 Mar;83:3-5. doi: 10.1016/j.jclinepi.2016.11.020. Epub 2017 Jan 17. No abstract available.

PMID:
28104463
24.

Seeking control in the midst of uncertainty: Women's experiences of choosing mode of birth after caesarean.

Munro S, Janssen P, Corbett K, Wilcox E, Bansback N, Kornelsen J.

Women Birth. 2017 Apr;30(2):129-136. doi: 10.1016/j.wombi.2016.10.005. Epub 2016 Oct 28.

PMID:
28029609
25.

Do Women Have a Choice? Care Providers' and Decision Makers' Perspectives on Barriers to Access of Health Services for Birth after a Previous Cesarean.

Munro S, Kornelsen J, Corbett K, Wilcox E, Bansback N, Janssen P.

Birth. 2017 Jun;44(2):153-160. doi: 10.1111/birt.12270. Epub 2016 Dec 5.

PMID:
27917532
26.

Communicating Uncertainty in Benefits and Harms: A Review of Patient Decision Support Interventions.

Bansback N, Bell M, Spooner L, Pompeo A, Han PKJ, Harrison M.

Patient. 2017 Jun;10(3):311-319. doi: 10.1007/s40271-016-0210-z. Review.

PMID:
27905072
27.

The burden of nonadherence among adults with asthma: a role for shared decision-making.

Pollard S, Bansback N, FitzGerld JM, Bryan S.

Allergy. 2017 May;72(5):705-712. doi: 10.1111/all.13090. Epub 2017 Jan 27. Review.

PMID:
27873330
28.

Use of network meta-analysis in clinical guidelines.

Kanters S, Ford N, Druyts E, Thorlund K, Mills EJ, Bansback N.

Bull World Health Organ. 2016 Oct 1;94(10):782-784. Epub 2016 Aug 30. No abstract available.

29.

Bar Code Medication Administration Technology: A Systematic Review of Impact on Patient Safety When Used with Computerized Prescriber Order Entry and Automated Dispensing Devices.

Shah K, Lo C, Babich M, Tsao NW, Bansback NJ.

Can J Hosp Pharm. 2016 Sep-Oct;69(5):394-402. Epub 2016 Oct 31. Review. No abstract available.

30.

Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis.

Kanters S, Vitoria M, Doherty M, Socias ME, Ford N, Forrest JI, Popoff E, Bansback N, Nsanzimana S, Thorlund K, Mills EJ.

Lancet HIV. 2016 Nov;3(11):e510-e520. doi: 10.1016/S2352-3018(16)30091-1. Epub 2016 Sep 6. Review.

PMID:
27658869
31.

Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality Improvement.

Yazdany J, Bansback N, Clowse M, Collier D, Law K, Liao KP, Michaud K, Morgan EM, Oates JC, Orozco C, Reimold A, Simard JF, Myslinski R, Kazi S.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1866-1873. doi: 10.1002/acr.23089.

32.

Using Discrete Choice Experiments with Duration to Model EQ-5D-5L Health State Preferences.

Mulhern B, Bansback N, Hole AR, Tsuchiya A.

Med Decis Making. 2017 Apr;37(3):285-297. doi: 10.1177/0272989X16670616. Epub 2016 Sep 29.

33.

Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study.

Zhang W, Bansback N, Sun H, Pedersen R, Kotak S, Anis AH.

RMD Open. 2016 Jul 7;2(2):e000222. doi: 10.1136/rmdopen-2015-000222. eCollection 2016.

34.

Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences.

Finckh A, Escher M, Liang MH, Bansback N.

Curr Rheumatol Rep. 2016 Aug;18(8):51. doi: 10.1007/s11926-016-0598-4. Review.

PMID:
27402108
35.

Attitude to health risk in the Canadian population: a cross-sectional survey.

Bansback N, Harrison M, Sadatsafavi M, Stiggelbout A, Whitehurst DG.

CMAJ Open. 2016 Jun 3;4(2):E284-91. doi: 10.9778/cmajo.20150071. eCollection 2016 Apr-Jun.

36.

Improving patient-centred care for rheumatoid arthritis.

Bansback N, Shojania K, Lacaille D.

CMAJ. 2016 Oct 4;188(14):999-1000. Epub 2016 Jun 27. No abstract available.

37.

DECIDE: a Decision Support Tool to Facilitate Parents' Choices Regarding Genome-Wide Sequencing.

Birch P, Adam S, Bansback N, Coe RR, Hicklin J, Lehman A, Li KC, Friedman JM.

J Genet Couns. 2016 Dec;25(6):1298-1308. Epub 2016 May 23.

PMID:
27211035
38.

A measurement framework for adherence in patient decision aid trials applied in a systematic review subanalysis.

Trenaman L, Selva A, Desroches S, Singh K, Bissonnette J, Bansback N, Stacey D.

J Clin Epidemiol. 2016 Sep;77:15-23. doi: 10.1016/j.jclinepi.2016.03.032. Epub 2016 May 13. Review.

PMID:
27185074
39.

Preferences for 'New' Treatments Diminish in the Face of Ambiguity.

Harrison M, Marra CA, Bansback N.

Health Econ. 2017 Jun;26(6):743-752. doi: 10.1002/hec.3353. Epub 2016 May 12.

PMID:
27174417
40.

Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment.

Penton H, Hiligsmann M, Harrison M, Reginster JY, Boonen A, Bansback N.

Osteoporos Int. 2016 Sep;27(9):2697-2707. doi: 10.1007/s00198-016-3596-5. Epub 2016 May 7.

PMID:
27155885
41.

Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohort.

Harvard S, Guh D, Bansback N, Richette P, Dougados M, Anis A, Fautrel B.

RMD Open. 2016 Apr 4;2(1):e000230. doi: 10.1136/rmdopen-2015-000230. eCollection 2016.

42.

How different are composite and traditional TTO valuations of severe EQ-5D-5L states?

Xie F, Pullenayegum E, Gaebel K, Bansback N, Bryan S, Ohinmaa A, Poissant L, Johnson JA.

Qual Life Res. 2016 Aug;25(8):2101-8. doi: 10.1007/s11136-016-1242-5. Epub 2016 Feb 13.

PMID:
26875190
43.

Making smart investment decisions in clinical research.

Bansback N, Keystone E, O'Dell J, Phibbs CS, Hannagan K, Brophy M, Anis A.

Trials. 2015 Dec 29;16:590. doi: 10.1186/s13063-015-1123-1.

44.

Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study.

Sayah FA, Bansback N, Bryan S, Ohinmaa A, Poissant L, Pullenayegum E, Xie F, Johnson JA.

Qual Life Res. 2016 Jul;25(7):1679-85. doi: 10.1007/s11136-015-1203-4. Epub 2015 Dec 10.

PMID:
26659899
45.

Choosing treatment and screening options congruent with values: Do decision aids help? Sub-analysis of a systematic review.

Munro S, Stacey D, Lewis KB, Bansback N.

Patient Educ Couns. 2016 Apr;99(4):491-500. doi: 10.1016/j.pec.2015.10.026. Epub 2015 Nov 2. Review.

PMID:
26549169
46.

Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study.

Zhang W, Bansback N, Sun H, Pedersen R, Kotak S, Anis AH.

RMD Open. 2015 Apr 8;1(1):e000042. doi: 10.1136/rmdopen-2014-000042. eCollection 2015.

47.

A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada.

Xie F, Pullenayegum E, Gaebel K, Bansback N, Bryan S, Ohinmaa A, Poissant L, Johnson JA; Canadian EQ-5D-5L Valuation Study Group.

Med Care. 2016 Jan;54(1):98-105. doi: 10.1097/MLR.0000000000000447.

48.

Development of a patient decision aid prototype for adults with obstructive sleep apnea.

Trenaman L, Munro S, Almeida F, Ayas N, Hicklin J, Bansback N.

Sleep Breath. 2016 May;20(2):653-61. doi: 10.1007/s11325-015-1269-9. Epub 2015 Oct 8.

PMID:
26449553
49.

Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments?

Bansback N, Harrison M, Marra C.

Med Decis Making. 2016 May;36(4):490-502. doi: 10.1177/0272989X15600708. Epub 2015 Aug 24.

PMID:
26304064
50.

The cost-effectiveness of patient decision aids: A systematic review.

Trenaman L, Bryan S, Bansback N.

Healthc (Amst). 2014 Dec;2(4):251-7. doi: 10.1016/j.hjdsi.2014.09.002. Epub 2014 Oct 3. Review.

PMID:
26250632

Supplemental Content

Loading ...
Support Center